9th April 2021 Content supplied by: Clent Life Science
Skip Extraction of SARS-CoV-2 with MicroLYSIS-RNA
If you’re using swabs or saliva samples for your COVID-19 RT-qPCR testing, then you should be using MicroLYSIS RNA because it is simple, efficient & effective.
Extraction using columns or beads has been considered the method for preparing RNA for reverse transcription and PCR amplification of SARS-CoV-2, but not anymore...
MicroLYSIS RNA has been shown to quickly and easily release RNA into a buffer that is ready and excellent for reverse transcription and PCR amplification of SARS-CoV-2.
MicroLYSIS RNA is a powerful reagent for use in COVID-19 testing by releasing RT-qPCR ready RNA from a range of samples that include:
- Dry Swabs
- Viral Transport Medium
The resulting lysate is in a ready-to-use format for downstream RT-qPCR testing.
Below we can see results of in-house sensitivity testing of MicroLYSIS RNA. The results are for concentrations of 22, 11, 6, and 3 copies/µl.
If you would like further details on MicroLYSIS RNA or any other Clent Life Science products, please use the 'Request Information' button provided below.
Date Published: 9th April 2021
Source article link: View
Need Higher Throughput Capabilities for
B.1.1.7, B.1.351, & P-1 Inactivated Whole